Abcellera Biologics Inc.
ABCL
Revenue
17.08M
▲12.85M▲303.40%
3 Months ChangeAssets
1.40B
▲57.85M▲4.30%
3 Months ChangeLiabilities
394.99M
▲73.76M▲22.96%
3 Months ChangeFree Cash Flow
-22.19M
▲43.66M▲66.30%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-06
Form 10-Q
ID: 0001628280-24-035248
2024-08-06
Form 8-K
ID: 0001628280-24-035229
2024-06-13
Form 8-K
ID: 0001628280-24-028097
2024-05-07
Form 10-Q
ID: 0001628280-24-021159
2024-05-07
Form 8-K
ID: 0001628280-24-021115
2024-02-23
Form 8-K
ID: 0001703057-24-000024
2024-02-20
Form 8-K
ID: 0001703057-24-000017
2023-11-28
Form 8-K
ID: 0001703057-23-000047
2023-11-02
Form 10-Q
ID: 0001703057-23-000040
2023-11-02
Form 8-K
ID: 0001703057-23-000038